Abstract

The present invention is directed to compounds or compositions comprising thereof, and to uses thereof such as for in prevention or treatment of a disease or a disorder associated with an elevated concentration of a branched chain amino acids (BCAA) within a subject.

IPC Classes  ?

• C07D 495/04 - Ortho-condensed systems
• C07D 517/04 - Ortho-condensed systems
• C07D 333/50 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
• C07D 343/00 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms
• A61K 31/381 - Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
• A61K 31/095 - Sulfur, selenium or tellurium compounds, e.g. thiols
• A61P 25/16 - Anti-Parkinson drugs
• A61P 3/00 - Drugs for disorders of the metabolism
• A61P 3/10 - Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
• A61P 9/04 - Inotropic agents, i.e. stimulants of cardiac contractionDrugs for heart failure